[Pharmacokinetics of the anti-hepatotoxic effect of silymarin in CCl4-and deoxycholate-induced liver damage in the rat].
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001647:Bile Acids and Salts / Q000506:poisoning; D002252:Carbon Tetrachloride Poisoning / Q000517:prevention & control; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000378:metabolism* / Q000517:prevention & control; D003840:Deoxycholic Acid / Q000506:poisoning; D005260:Female; D005419:Flavonoids / Q000008:administration & dosage / Q000627:therapeutic use*; D005969:Glutamate Dehydrogenase / Q000097:blood; D007274:Injections, Intraperitoneal; D010088:Oxidoreductases / Q000097:blood; D051381:Rats; D013012:Sorbitol; D013997:Time Factors
D001647:Bile Acids and Salts; D005419:Flavonoids; D003840:Deoxycholic Acid; D013012:Sorbitol; D010088:Oxidoreductases; D005969:Glutamate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Die Pharkokinetik der antiheoatotoxischen Wirkung des Silymarins bei der Leberschädigung der Ratte durch CCl4 und Desoxycholat.